Clopamide
Suppliers
Names
[ CAS No. ]:
636-54-4
[ Name ]:
Clopamide
[Synonym ]:
EINECS 211-261-7
Brinaldix
DT-327
4-Chloro-N-[(2R,6S)-2,6-dimethyl-1-piperidinyl]-3-sulfamoylbenzamide
Benzamide, 3-(aminosulfonyl)-4-chloro-N-(2,6-dimethyl-1-piperidinyl)-, cis-
CLOPAMIDUM
ChlosudiMepriMyl
Adurix
MFCD00941495
4-Chloro-N-(2,6-dimethylpiperidino)-3-sulfamoylbenzamide
3-(aminosulfonyl)-4-chloro-N-(2,6-dimethylpiperidin-1-yl)benzamide
Aquex
4-Chloro-N-(2,6-dimethylpiperidin-1-yl)-3-sulfamoylbenzamide
Benzamide, 3-(aminosulfonyl)-4-chloro-N-[(2R,6S)-2,6-dimethyl-1-piperidinyl]-
Benzamide, 3-(aminosulfonyl)-4-chloro-N-(2,6-dimethyl-1-piperidinyl)-
4-Chloro-N-(2,6-dimethyl-1-piperidinyl)-3-sulfamoylbenzamide
Chemical & Physical Properties
[ Density]:
1.4±0.1 g/cm3
[ Melting Point ]:
244-246ºC
[ Molecular Formula ]:
C14H20ClN3O3S
[ Molecular Weight ]:
345.845
[ Exact Mass ]:
345.091400
[ PSA ]:
100.88000
[ LogP ]:
1.59
[ Index of Refraction ]:
1.613
[ Storage condition ]:
2-8°C
Safety Information
[ Symbol ]:
GHS08
[ Signal Word ]:
Danger
[ Hazard Statements ]:
H317-H334
[ Precautionary Statements ]:
P261-P280-P284-P304 + P340-P342 + P311
[ Hazard Codes ]:
Xn
[ Risk Phrases ]:
R42/43
[ Safety Phrases ]:
36
[ RIDADR ]:
NONH for all modes of transport
[ WGK Germany ]:
3
[ HS Code ]:
2935009090
Customs
[ HS Code ]: 2935009090
[ Summary ]:
2935009090 other sulphonamides VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:35.0%
Articles
Anal. Chim. Acta 853 , 637-46, (2014)
The conditions for the analysis of selected doping substances by UHPSFC-MS/MS were optimized to ensure suitable peak shapes and maximized MS responses. A representative mixture of 31 acidic and basic ...
Anal. Chim. Acta 853 , 647-59, (2014)
The potential and applicability of UHPSFC-MS/MS for anti-doping screening in urine samples were tested for the first time. For this purpose, a group of 110 doping agents with diverse physicochemical p...
Med. J. Aust. 150(11) , 646, 648, 651-2, (1989)
In an open study that was conducted in general practice, 22 patients with previously-untreated mild hypertension received an average daily dose of 11.7 mg of pindolol over a 50-week study period. The ...